Codexis
Biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics. Learn more
Launch date
Employees
Market cap
€179m
Enterprise valuation
€151m (Public information from Sep 2024)
Share price
$3.21 CDXS
Redwood City California (HQ)
Authorizing premium user...